In addition, transferring IL-21-expressing CD4 T cells into B16F10 tumor-bearing mice enhanced the proliferation of CX3C chemokine receptor 1+ CD8 TILs, which correlated with improved tumor control. The gene discussed is CX3CR1; the disease is neoplasm.